Mega Medical Technology Limited announced earnings unaudited guidance for the six months ended June 30, 2016. For the six months, the company expected profit in the results for the six months ended 30 June 2016 as compared with a loss in the corresponding period in 2015. The Board considers that the turnaround in the results for the Interim Period as compared to the corresponding period in 2015 is principally attributable to the significant increase in gross profit and gross margin generated from the dental prosthetics business and the gain on disposal of subsidiaries as compared to the corresponding period in 2015.